Is symptom burden associated with treatment status and disease stage among adult HIV outpatients in east Africa?

Journal of Palliative Medicine

Volumn 17, Issue 3, 2014, Pages 304-312

  Namisango, Eve ^a   Powell, Richard A ^b   Atuhaire, Leonard ^c   Katabira, Elly T ^c   Mwangi Powell, Faith ^d   Harding, Richard ^e,f  

^a AFRICAN PALLIATIVE CARE ASSOCIATION   (Uganda)

^b HealthCare Chaplaincy   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

^d OPEN SOCIETY FOUNDATIONS   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFRICA; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; DISTRESS SYNDROME; DROWSINESS; FATIGUE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNGER; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MEMORIAL SYMPTOM ASSESSMENT SCALE; NERVOUSNESS; OUTPATIENT; PATIENT WORRY; PREVALENCE; RATING SCALE; SELF REPORT; SEX DIFFERENCE; SYMPTOMATOLOGY; COMPLICATION; COST OF ILLNESS; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MIDDLE AGED; PSYCHOLOGY; RISK; UGANDA;

ACTIVITIES OF DAILY LIVING; ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; ODDS RATIO; SELF REPORT; SEX FACTORS; UGANDA;

EID: 84896308021     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2013.0291     Document Type: Article

References (31)

1. Selwyn PA, Rivard M: Palliative care for AIDS: Challenges and opportunities in the era of highly active anti-retroviral therapy. Innov End Life Care 2003;6:475-487.
2. Simms V, Higginson IJ, Harding R: What palliative care-related problems do patients experience at HIV diagnosis? A systematic review of the evidence. J Pain Symptom Manage 2011;42:734-753.
3. Harding R, Lampe FC, Norwood S, Date HL, Clucas C, Fisher M, Johnson M, Edwards S, Anderson J, Sherr L: Symptoms are highly prevalent among HIV outpatients and associated with poor adherence and unprotected sexual intercourse. Sex Transm Infect 2010;86:520-524.
4. Harding R, Selman L, Agupio G, Dinat N, Downing J, Gwyther L, Mashao T, Mmoledi K, Moll T, Sebuyira LM, Ikin B, Higginson IJ: Prevalence, burden, and correlates of physical and psychological symptoms among HIV palliative care patients in Sub-Saharan Africa: An international mul-ticenter study. J Pain Symptom Manage 2012;44:1-9.
5. Wakeham K, Harding R, Bamukama-Namakoola D, Levin J, Kissa J, Parkes-Ratanshi R, Muzaaya G, Grosskurth H, Lalloo DG: Symptom burden in HIV-infected adults at time of HIV diagnosis in rural Uganda. J Palliat Med 2010;13:375-380.
6. Farrant L, Gwyther L, Dinat N, Harding R: The prevalence and burden of pain and other symptoms among South Africans attending highly active antiretroviral therapy (HAART) clinics. S Afr Med J 2012;102:499-500.
7. Heath KV, Montaner JS, Bondy G, Singer J, O'Shaughnessy MV, Hogg RS: Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection. Curr Drug Targets 2003;4:13-22.
8. Sherr L, Harding R: Adherence to antiretroviral treatment in patients with HIV in the UK: A study of complexity. AIDS Care 2008;20:442-448.
9. Wachtel T, Piette J, Mor V, Stein M, Fleisheman J, Carpenter C: Quality of life in persons with human immunodeficiency virus infection: Measurement by the Medical Outcomes Study instrument. Ann Intern Med 1992;116:129-137.
10. Harding R, Clucas C, Lampe FC, Date HL, Fisher M, Johnson M, Edwards S, Anderson J, Sherr L: What factors are associated with patient self-reported health status among HIV outpatients? A multi-centre UK study of biomedical and psychosocial factors. AIDS Care 2012;8:963-971.
11. Cleary PD, Fowler FJ, Weissman J, Massagli MP, Seage GR 3rd, Gatsonis C, Epstein A: Health-related quality of life in persons with acquired immune deficiency syndrome. Med Care 1993;31:569-580.
12. Revicki DA, Wu AW, Murray MI: Change in clinical status, health status, and health utility outcomes in HIV-infected patients. Med Care 1995;33:AS173-AS182.
13. World Health Organization: Palliative Care. World Health Organization, 2005. www.who.int/hiv/topics/palliative/PalliativeCare/en/. (Last accessed October 22, 2012).
14. Holzemer WL, Hudson A, Kirksey KM, Hamilton MJ, Bak-ken S: The revised sign and symptom check-list for HIV (SSC-HIV rev). J Assoc Nurses AIDS Care 2001;61:60-70.
15. Harding R, Selman L, Agupio G, Dinat N, Downing J, Gwyther L, Mashao T, Mmoledi K, Sebuyira LM, Ikin B, Higginson IJ: The prevalence and burden of symptoms amongst cancer patients attending palliative care in two African countries. Eur J Cancer 2011;47:51-56.
16. Justice AC, Chang CH, Rabeneck L Zackin R: Clinical importance of provider-reported HIV symptoms compared with patient-report. Med Care 2001;39:397-408.
17. Karus D, Raveis VH, Alexander C, Hanna B, Selwyn P. Marconi K, Higginson IJ: Patient reports of symptoms and their treatment at three palliative care projects servicing individuals with HIV/AIDS. J Pain Symptom Manage 2005;30:408-417.
18. Selwyn P: Why should we care about palliative care for AIDS in the era of antiretroviral therapy? Sex Transm Infect 2005;81:2-3.
19. Potter J, Hami F, Bryan T, Quigley C: Symptoms in 400 patients referred to palliative care services: Prevalence and patterns. Palliat Med 2003;17:310-314.
20. Vogl D, Rosenfeld B, Breitbart W, Thaler H, Passik S, McDonald M, Portenoy RK: Symptom prevalence, characteristics, and distress in AIDS outpatients. J Pain Symptom Manage 1999;18:253-262.
21. Dawson J, Doll H, Fitzpatrick R, Jenkinson C, Carr AJ: The routine use of patient-reported outcome measures (PROMs) in health care settings. BMJ 2010;340:186.
22. Willard S, Holzemer WL, Wantland DJ, Cuca YP, Kirksey KM, Portillo CJ, Corless IB, Rivero-Mendez M, Rosa ME, Nicholas PK, Hamiltom MJ, Sefcik E, Kemppainen J, Cana-val G, Robinso L, Moezzi S, Human S, Arudo J, Eller LS, Bunch E, Dole PJ, Coleman C, Nokes K, Reynolds NR, Tsai YF, Maryland M, Voss J, Lindgren T: Does 'asymptomatic' mean without symptoms for those living with HIV infection? AIDS Care 2009;21:322-328.
23. Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM (ed): Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949, pp. 199-205.
24. Katwere M, Kambugu A, Piloya T, Wong M, Hendel-Paterson B, Sande MA, Ronald A, Katabira E, Were EM, Menten J, Colebunders R: Clinical presentation and aetiologies of acute or complicated headache among HIV sero-positive patients in a Ugandan clinic. J Int AIDS Soc 2009;12:1-8.
25. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Fried-lander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Nortin L: The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994;30A:1326-1336.
26. Kleinbaum DG, Kupper Nizzam AL, Muller KE (eds): Applied Regression Analysis and Other Multivariate Methods, 3rd ed. New York: Duxbury Press, 1998.
27. Yoichi Chida Y, Vedhara K: Adverse psychosocial factors predict poorer prognosis in HIV disease: A meta-analytic review of prospective investigations. Brain Behavior Im-munit 2009;23:434-445.
28. Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogenyi R, Oyabba T, Temu F, Laing R: Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa. AIDS Care 2007;19:658-665.
29. Bangsberg DR, Hecht FM, Charlebois ED Zolopa AR, Ho-lodny M, Sheiner L, Bamberger JD, Chesney MA, Moss A, et al.: Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14:357-366.
30. Mosha F, Muchunguzi V, Matee M, Sangenda R, Vercau-teren J, Nsubuga P, Lyamuya E, Vadamme AM: Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting anti-retroviral treatment (ART) in Dar es Salaam, Tanzania. BMC Public Health 2013;13:38.
31. Kanters S, Nsubuga M, Mwehire D, Odiit M, Kasirye M, Musoke W, Druyts E, Yaya S, Funk A, Ford N, Mills EJ: Increased mortality among HIV-positive men on antiretroviral therapy: Survival differences between sexes explained by late initiation in Uganda. HIV/AIDS Research Palliat Care 2013; 5:111-119.